Glaucoma, open-angle
Clinical trials for Glaucoma, open-angle explained in plain language.
Never miss a new study
Get alerted when new Glaucoma, open-angle trials appear
Sign up with your email to follow new studies for Glaucoma, open-angle, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye drop combo study for glaucoma halted early
Disease control Stopped earlyThis study tested two different combinations of eye drops to lower eye pressure in people with open-angle glaucoma or ocular hypertension. The goal was to see which combination worked better over 90 days. The study was stopped early and included 28 participants.
Matched conditions: GLAUCOMA, OPEN-ANGLE
Phase 4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Glaucoma device showdown ends early: only 10 patients enrolled
Disease control Stopped earlyThis study aimed to compare two surgical devices—the OMNI system and the iStent inject—for lowering eye pressure in people with open-angle glaucoma who already had cataract surgery. The trial was terminated early and only enrolled 10 participants, so results are limited. Both dev…
Matched conditions: GLAUCOMA, OPEN-ANGLE
Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Glaucoma implant trial halted early – what we know
Disease control Stopped earlyThis study tested a new medical device called Supraflow v1.3, which is implanted in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. The trial included 22 patients whose eye pressure was not controlled with medication. However, the study was term…
Matched conditions: GLAUCOMA, OPEN-ANGLE
Sponsor: Ciliatech • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC